Apollo Global Management stock gains on $20 billion DePuy Synthes talks
Published on 09/14/2026 at 19:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Apollo Global Management stock (ISIN US0376123065) is trading with a corporate spotlight as reports on September 14, 2026 highlight talks to acquire Johnson & Johnson’s DePuy Synthes orthopedics unit in a deal that could be valued at close to 20 billion dollars, while the shares remain supported by a broadly positive analyst stance and a solid fundamental base.
Deal talks around DePuy Synthes
According to Economic Times on September 14, 2026, Apollo Global Management is in talks to acquire Johnson & Johnson’s orthopedics unit, DePuy Synthes, in a transaction that could value the business at close to 20 billion dollars.
Investing.com reports that Johnson & Johnson shares rose to 268.96 dollars in premarket trading on September 14, 2026 after investors reacted to the news that Apollo Global Management is in discussions to buy the company’s orthopedics unit at a valuation close to 20 billion dollars, underlining how the potential deal is already influencing sentiment around the buyer as well as the seller.
As AK&M noted on September 14, 2026, Apollo expects to buy out Johnson & Johnson’s orthopedic business for around 20 billion dollars, which would mark one of the largest buyout transactions in the healthcare sector and potentially expand Apollo’s exposure to medical devices alongside its existing diversified alternative asset portfolio.
Analyst view and rating backdrop
The analyst backdrop remains constructive for Apollo Global Management stock and provides important context for investors weighing the DePuy Synthes talks. According to MarketBeat on September 14, 2026, JPMorgan Chase & Co. raised its price objective for Apollo Global Management shares from 150.00 dollars to 154.00 dollars on September 2, 2026 and maintained an overweight rating, signaling confidence in the company’s earnings and asset growth trajectory.
The same MarketBeat overview highlights that one analyst currently rates Apollo Global Management stock as Strong Buy, twelve as Buy and four as Hold, resulting in an average rating categorized as Moderate Buy and an average price target of 152.15 dollars, which sits noticeably above the recent trading levels and illustrates a favorable consensus compared with the actual market price.
The implied upside can be illustrated numerically: if the shares trade around the low-130-dollar range, an average price target of 152.15 dollars points to a potential gain of roughly 15 percent from that level, even before factoring in the impact of any successfully executed 20 billion dollar acquisition in orthopedics on Apollo’s fee streams and investment returns.
Fundamental scale and risk perspective
Beyond the immediate deal headlines, Apollo Global Management’s fundamental scale is a central part of the story. As Axios reported on September 14, 2026, Apollo Global Management had more than 1 trillion dollars in assets under management as of the second quarter of 2026, underscoring how the group has grown into one of the largest alternative asset managers globally.
This sheer size brings both opportunity and risk. In the same interview cited by Axios, financial journalist William Cohan stated that Apollo Global Management, given its scale and leverage in various markets, could absolutely trigger a financial crisis under adverse circumstances, offering investors a cautionary note that complements the growth narrative and reminding them to weigh downside scenarios alongside the upside from large acquisitions.
From a portfolio perspective, the potential addition of a 20 billion dollar orthopedics business would represent about 2 percent of Apollo’s more than 1 trillion dollars in assets under management, based on the second-quarter 2026 figure reported by Axios, giving investors a sense of the relative scale of the transaction compared with the overall platform.
Stock price level and recent trading range
For investors watching Apollo Global Management stock day to day, the key reference price lies on the New York Stock Exchange in United States dollars. Per recent real-time estimates on September 14, 2026, the shares changed hands around 126.61 dollars on the primary listing, representing a decline of 5.28 percent over the prior five trading days and a loss of 2.13 percent since the start of the year, according to the trading overview for the APOUS line on Zonebourse as of the evening of September 14, 2026.
This five-day drop of 5.28 percent contrasts with the supportive analyst backdrop described by MarketBeat, where the average price target of 152.15 dollars stands more than 25 dollars above the recent price, illustrating a noticeable gap between current trading levels and the longer-term expectations embedded in Street models.
Extended-hours indications have been relatively muted around the deal headlines. A premarket print of 128.19 dollars for APO at 6:32 a.m. ET on September 14, 2026, around 0.2 percent above the prior close of 127.91 dollars, was cited by TS2, but the early timestamp and thin extended-hours trading make that quote only a tentative signal rather than a settled verdict on the DePuy Synthes story.
Governance considerations and co-founder exposure
The governance angle also plays into the broader risk assessment for Apollo Global Management stock. As TS2 reported on September 14, 2026, the House Oversight Committee is scheduled to meet at 4 p.m. ET on September 15, 2026 to consider a resolution recommending that the full House hold Apollo co-founder Leon Black in contempt for defying subpoenas related to investigations into his business dealings.
The same TS2 article stresses that Apollo’s exposure to these proceedings is described as indirect, as Black stepped down from executive roles at the firm in earlier years, but the reputational dimension of any high-profile Congressional contempt case involving a co-founder can still weigh on investor perception, especially when combined with systemic-risk concerns like those raised by William Cohan in the interview cited by Axios.
For shareholders, this mix of a large prospective acquisition, supportive analyst targets, immense assets under management and governance noise creates a complex picture in which both upside and downside drivers are numerically tangible: a 20 billion dollar deal that is large but still modest versus 1 trillion dollars of assets under management, a five-day share price decline of 5.28 percent even as the average price target sits more than 15 percent above spot, and potential reputational overhangs whose market impact will become clearer once the House and regulators take further visible steps.
Apollo Global Management stock on the NYSE
Apollo Global Management stock is listed on the New York Stock Exchange under the ticker APO, with United States dollars as the trading currency. As of September 14, 2026, the shares were quoted around 126.61 dollars on the primary listing, according to the real-time overview for APOUS, with the price movement over the preceding five trading days showing a decline of 5.28 percent that leaves the stock some distance below the average analyst price target of 152.15 dollars but still underpinned by more than 1 trillion dollars in assets under management as of the second quarter of 2026.
Key data on Apollo Global Management stock
- Company: Apollo Global Management Inc.
- ISIN: US0376123065
- Ticker: APO
- Trading venue: NYSE
- Price (as of September 14, 2026): 126.61 USD
- Sector / Industry: Financials / Alternative asset management
- Index membership: S&P 500
